Literature DB >> 34241575

Can children of the Sputnik V vaccine recipients become symptomatic?

Esmaeil Mehraeen1, SeyedAhmad SeyedAlinaghi2, Amirali Karimi3.   

Abstract

Sputnik V is one of the most promising vaccines, utilizing an Adenovirus vector to cause immunity against SARS-CoV-2. Concerns existed against Adenovirus infection with this vaccine, although seemed to be a rare event. In this study, we observed that 15/18 (83%) of the children of the Sputnik V recipients became symptomatic and developed transient fever and chills for 1-2 days starting after 2-5 days following the vaccination of their parents that can be related to an Adenovirus infection. To our knowledge, this is the first study reporting such symptoms in the children of Sputnik V recipients, and the results should be validated by larger studies.

Entities:  

Keywords:  Adverse events; COVID-19; SARS-COV-2; Sputnik V; vaccine

Year:  2021        PMID: 34241575     DOI: 10.1080/21645515.2021.1933689

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  5 in total

1.  Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.

Authors:  Rafael Guerrero-Preston; Vanessa Rivera-Amill; Karem Caraballo; Sebastian Rodríguez-Torres; Ana Purcell-Wiltz; Andrea A García; Raphael S Torres; Fernando T Zamuner; Claudio Zanettini; Matthew J MacKay; Rachel Baits; Daisy Salgado; Gaurav Khullar; Jessica Metti; Timothy Baker; Joel Dudley; Keilyn Vale; Gabriela Pérez; Lorena De Jesús; Yaima Miranda; Denise Ortiz; Amanda García-Negrón; Liliana Viera; Alberto Ortiz; Jorge A Canabal; Josefina Romaguera; Ivonne Jiménez-Velázquez; Luigi Marchionni; José F Rodríguez-Orengo; Adriana Baez; Christopher E Mason; David Sidransky
Journal:  Immun Inflamm Dis       Date:  2022-06

2.  Effect Analysis of "Four-Step" Training and Assessment Tool in the Prevention and Control of COVID-19.

Authors:  Bin Han; Feng Zang; Juan Liu; Songqin Li; Weihong Zhang; Yongxiang Zhang; Zhanjie Li
Journal:  Infect Drug Resist       Date:  2022-03-24       Impact factor: 4.003

3.  Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎.

Authors:  Omid Dadras; SeyedAhmad SeyedAlinaghi; Amirali Karimi; Ahmadreza Shamsabadi; Sara Mahdiabadi; Parsa Mohammadi; Ava Amiri; Alireza Shojaei; Zahra Pashaei; Pegah Mirzapour; Kowsar Qaderi; Mehrzad MohsseniPour; Sanam Alilou; Esmaeil Mehraeen; Shayesteh Jahanfar
Journal:  Hum Vaccin Immunother       Date:  2022-03-23       Impact factor: 4.526

Review 4.  COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review.

Authors:  Omid Dadras; SeyedAhmad SeyedAlinaghi; Amirali Karimi; Alireza Shojaei; Ava Amiri; Sara Mahdiabadi; Amirata Fakhfouri; Armin Razi; Hengameh Mojdeganlou; Paniz Mojdeganlou; Alireza Barzegary; Zahra Pashaei; Amir Masoud Afsahi; Parnian Shobeiri; Esmaeil Mehraeen
Journal:  Arch Acad Emerg Med       Date:  2022-07-04

Review 5.  Viral vector and nucleic acid vaccines against COVID-19: A narrative review.

Authors:  Saeed Khoshnood; Roya Ghanavati; Maryam Shirani; Hossein Ghahramanpour; Mohammad Sholeh; Aref Shariati; Nourkhoda Sadeghifard; Mohsen Heidary
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.